ABX464 (Obefazimod) Upregulates miR-124 to Reduce Proinflammatory Markers in Inflammatory Bowel Diseases

por Apolit, Cécile, Campos, Noëlie, Vautrin, Audrey, Begon-Pescia, Christina, Lapasset, Laure, Scherrer, Didier, Gineste, Paul, Ehrlich, Hartmut, Garcel, Aude, Santo, Julien, Tazi, Jamal
Publicado 2022

Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing

por Vautrin, Audrey, Manchon, Laurent, Garcel, Aude, Campos, Noëlie, Lapasset, Laure, Laaref, Abdelhamid Mahdi, Bruno, Roman, Gislard, Marie, Dubois, Emeric, Scherrer, Didier, Ehrlich, J Hartmut, Tazi, Jamal
Publicado 2019

Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis

por Campos, Noëlie, Myburgh, Renier, Garcel, Aude, Vautrin, Audrey, Lapasset, Laure, Nadal, Erika Schläpfer, Mahuteau-Betzer, Florence, Najman, Romain, Fornarelli, Pauline, Tantale, Katjana, Basyuk, Eugénia, Séveno, Martial, Venables, Julian P, Pau, Bernard, Bertrand, Edouard, Wainberg, Mark A, Speck, Roberto F, Scherrer, Didier, Tazi, Jamal
Publicado 2015